First, to our knowledge, this is the first meta-analysis based on epidemiological evidence to quantitatively evaluate the association between diabetic status and tumor stage, as well as tumor size; tumor grade; and ER, PR, and Her2 status in women diagnosed with breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.